In this article, we will discuss Epirubicin (Dosage Overview). So, let’s get started.
Epirubicin Injection is indicated as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer.
When possible, to reduce the risk of developing cardiotoxicity in patients receiving Epirubicin after stopping treatment with other cardiotoxic agents, especially those with long half-lives such as trastuzumab, Epirubicin-based therapy should be delayed until the other agents have cleared from the circulation.
Administer Epirubicin Injection by intravenous infusion. Give Epirubicin in repeated 3- to 4-week cycles. The total dose of Epirubicin may be given on Day 1 of each cycle or divided equally and given on Days 1 and 8 of each cycle.
The recommended dose of Epirubicin is 100 to 120 mg/m².